nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0856	0.109	CbGbCtD
Methadone—CYP3A7—Sorafenib—thyroid cancer	0.0856	0.109	CbGbCtD
Methadone—CYP2B6—Sorafenib—thyroid cancer	0.0815	0.104	CbGbCtD
Methadone—CYP3A5—Sorafenib—thyroid cancer	0.0642	0.082	CbGbCtD
Methadone—CYP2C8—Sorafenib—thyroid cancer	0.0617	0.0789	CbGbCtD
Methadone—CYP2C19—Sorafenib—thyroid cancer	0.0518	0.0662	CbGbCtD
Methadone—CYP2B6—Doxorubicin—thyroid cancer	0.0494	0.0632	CbGbCtD
Methadone—CYP1A2—Sorafenib—thyroid cancer	0.0478	0.061	CbGbCtD
Methadone—CYP2C9—Sorafenib—thyroid cancer	0.043	0.055	CbGbCtD
Methadone—ABCB1—Sorafenib—thyroid cancer	0.0418	0.0534	CbGbCtD
Methadone—CYP3A4—Vandetanib—thyroid cancer	0.0415	0.0531	CbGbCtD
Methadone—CYP2D6—Sorafenib—thyroid cancer	0.0394	0.0503	CbGbCtD
Methadone—ABCB1—Doxorubicin—thyroid cancer	0.0253	0.0324	CbGbCtD
Methadone—CYP3A4—Sorafenib—thyroid cancer	0.025	0.032	CbGbCtD
Methadone—CYP2D6—Doxorubicin—thyroid cancer	0.0239	0.0305	CbGbCtD
Methadone—CYP3A4—Doxorubicin—thyroid cancer	0.0152	0.0194	CbGbCtD
Methadone—Respiratory arrest—Vandetanib—thyroid cancer	0.00916	0.0478	CcSEcCtD
Methadone—Hypomagnesaemia—Vandetanib—thyroid cancer	0.00634	0.0331	CcSEcCtD
Methadone—Electrocardiogram QT prolonged—Vandetanib—thyroid cancer	0.00627	0.0328	CcSEcCtD
Methadone—Torsade de pointes—Vandetanib—thyroid cancer	0.00574	0.03	CcSEcCtD
Methadone—Rhinorrhoea—Sorafenib—thyroid cancer	0.00335	0.0175	CcSEcCtD
Methadone—Cardiac failure—Vandetanib—thyroid cancer	0.003	0.0156	CcSEcCtD
Methadone—Glossitis—Sorafenib—thyroid cancer	0.00295	0.0154	CcSEcCtD
Methadone—Drug interaction—Sorafenib—thyroid cancer	0.00293	0.0153	CcSEcCtD
Methadone—Cardiac arrest—Vandetanib—thyroid cancer	0.00278	0.0145	CcSEcCtD
Methadone—Hypokalaemia—Vandetanib—thyroid cancer	0.00266	0.0139	CcSEcCtD
Methadone—Nasopharyngitis—Vandetanib—thyroid cancer	0.00261	0.0136	CcSEcCtD
Methadone—Weight decreased—Vandetanib—thyroid cancer	0.00229	0.0119	CcSEcCtD
Methadone—Bradycardia—Vandetanib—thyroid cancer	0.00206	0.0107	CcSEcCtD
Methadone—Cardiac failure—Sorafenib—thyroid cancer	0.00202	0.0105	CcSEcCtD
Methadone—Cardiomyopathy—Epirubicin—thyroid cancer	0.00196	0.0102	CcSEcCtD
Methadone—Visual impairment—Vandetanib—thyroid cancer	0.00195	0.0102	CcSEcCtD
Methadone—Cardiomyopathy—Doxorubicin—thyroid cancer	0.00182	0.00948	CcSEcCtD
Methadone—Arrhythmia—Vandetanib—thyroid cancer	0.00181	0.00943	CcSEcCtD
Methadone—Hypokalaemia—Sorafenib—thyroid cancer	0.00179	0.00937	CcSEcCtD
Methadone—Body temperature decreased—Epirubicin—thyroid cancer	0.00179	0.00935	CcSEcCtD
Methadone—Hypothermia—Epirubicin—thyroid cancer	0.00179	0.00935	CcSEcCtD
Methadone—Nasopharyngitis—Sorafenib—thyroid cancer	0.00176	0.00921	CcSEcCtD
Methadone—Lacrimation—Epirubicin—thyroid cancer	0.00171	0.00891	CcSEcCtD
Methadone—Muscle spasms—Vandetanib—thyroid cancer	0.00169	0.00884	CcSEcCtD
Methadone—Hypothermia—Doxorubicin—thyroid cancer	0.00166	0.00865	CcSEcCtD
Methadone—Body temperature decreased—Doxorubicin—thyroid cancer	0.00166	0.00865	CcSEcCtD
Methadone—Tremor—Vandetanib—thyroid cancer	0.00165	0.00861	CcSEcCtD
Methadone—Hypomagnesaemia—Epirubicin—thyroid cancer	0.00158	0.00825	CcSEcCtD
Methadone—Lacrimation—Doxorubicin—thyroid cancer	0.00158	0.00825	CcSEcCtD
Methadone—Loss of consciousness—Vandetanib—thyroid cancer	0.00155	0.00808	CcSEcCtD
Methadone—Weight decreased—Sorafenib—thyroid cancer	0.00154	0.00805	CcSEcCtD
Methadone—Convulsion—Vandetanib—thyroid cancer	0.00153	0.00796	CcSEcCtD
Methadone—Anxiety—Vandetanib—thyroid cancer	0.00149	0.0078	CcSEcCtD
Methadone—Redness—Epirubicin—thyroid cancer	0.00149	0.00776	CcSEcCtD
Methadone—Dry mouth—Vandetanib—thyroid cancer	0.00147	0.00765	CcSEcCtD
Methadone—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.00146	0.00763	CcSEcCtD
Methadone—Oedema—Vandetanib—thyroid cancer	0.00144	0.0075	CcSEcCtD
Methadone—Lung disorder—Epirubicin—thyroid cancer	0.00142	0.00741	CcSEcCtD
Methadone—Thrombocytopenia—Vandetanib—thyroid cancer	0.00141	0.00734	CcSEcCtD
Methadone—Redness—Doxorubicin—thyroid cancer	0.00138	0.00718	CcSEcCtD
Methadone—Lung disorder—Doxorubicin—thyroid cancer	0.00131	0.00685	CcSEcCtD
Methadone—Insomnia—Vandetanib—thyroid cancer	0.0013	0.00678	CcSEcCtD
Methadone—Flushing—Sorafenib—thyroid cancer	0.00127	0.00661	CcSEcCtD
Methadone—Decreased appetite—Vandetanib—thyroid cancer	0.00125	0.00652	CcSEcCtD
Methadone—Pain—Vandetanib—thyroid cancer	0.00123	0.00641	CcSEcCtD
Methadone—Constipation—Vandetanib—thyroid cancer	0.00123	0.00641	CcSEcCtD
Methadone—Arrhythmia—Sorafenib—thyroid cancer	0.00122	0.00636	CcSEcCtD
Methadone—Erythema—Sorafenib—thyroid cancer	0.00119	0.0062	CcSEcCtD
Methadone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00118	0.00613	CcSEcCtD
Methadone—Amenorrhoea—Epirubicin—thyroid cancer	0.00114	0.00597	CcSEcCtD
Methadone—Muscle spasms—Sorafenib—thyroid cancer	0.00114	0.00596	CcSEcCtD
Methadone—Abdominal pain—Vandetanib—thyroid cancer	0.00114	0.00593	CcSEcCtD
Methadone—Body temperature increased—Vandetanib—thyroid cancer	0.00114	0.00593	CcSEcCtD
Methadone—Lacrimation increased—Epirubicin—thyroid cancer	0.00109	0.00569	CcSEcCtD
Methadone—Glossitis—Epirubicin—thyroid cancer	0.00109	0.00569	CcSEcCtD
Methadone—Syncope—Sorafenib—thyroid cancer	0.00107	0.00556	CcSEcCtD
Methadone—Amenorrhoea—Doxorubicin—thyroid cancer	0.00106	0.00552	CcSEcCtD
Methadone—Loss of consciousness—Sorafenib—thyroid cancer	0.00104	0.00545	CcSEcCtD
Methadone—Asthenia—Vandetanib—thyroid cancer	0.00103	0.00538	CcSEcCtD
Methadone—Pruritus—Vandetanib—thyroid cancer	0.00102	0.00531	CcSEcCtD
Methadone—Glossitis—Doxorubicin—thyroid cancer	0.00101	0.00526	CcSEcCtD
Methadone—Lacrimation increased—Doxorubicin—thyroid cancer	0.00101	0.00526	CcSEcCtD
Methadone—Ventricular tachycardia—Epirubicin—thyroid cancer	0.001	0.00524	CcSEcCtD
Methadone—Dermatitis contact—Epirubicin—thyroid cancer	0.000992	0.00518	CcSEcCtD
Methadone—Dry mouth—Sorafenib—thyroid cancer	0.000989	0.00516	CcSEcCtD
Methadone—Diarrhoea—Vandetanib—thyroid cancer	0.000983	0.00513	CcSEcCtD
Methadone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000969	0.00506	CcSEcCtD
Methadone—Shock—Sorafenib—thyroid cancer	0.000954	0.00498	CcSEcCtD
Methadone—Dizziness—Vandetanib—thyroid cancer	0.00095	0.00496	CcSEcCtD
Methadone—Thrombocytopenia—Sorafenib—thyroid cancer	0.000949	0.00495	CcSEcCtD
Methadone—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000929	0.00485	CcSEcCtD
Methadone—Anorexia—Sorafenib—thyroid cancer	0.000924	0.00482	CcSEcCtD
Methadone—Dermatitis contact—Doxorubicin—thyroid cancer	0.000918	0.00479	CcSEcCtD
Methadone—Vomiting—Vandetanib—thyroid cancer	0.000914	0.00477	CcSEcCtD
Methadone—Rash—Vandetanib—thyroid cancer	0.000906	0.00473	CcSEcCtD
Methadone—Dermatitis—Vandetanib—thyroid cancer	0.000905	0.00473	CcSEcCtD
Methadone—Headache—Vandetanib—thyroid cancer	0.0009	0.0047	CcSEcCtD
Methadone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000894	0.00467	CcSEcCtD
Methadone—Nausea—Vandetanib—thyroid cancer	0.000854	0.00446	CcSEcCtD
Methadone—Phlebitis—Epirubicin—thyroid cancer	0.000846	0.00442	CcSEcCtD
Methadone—Decreased appetite—Sorafenib—thyroid cancer	0.000843	0.0044	CcSEcCtD
Methadone—Constipation—Sorafenib—thyroid cancer	0.000829	0.00433	CcSEcCtD
Methadone—Pain—Sorafenib—thyroid cancer	0.000829	0.00433	CcSEcCtD
Methadone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000827	0.00432	CcSEcCtD
Methadone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000793	0.00414	CcSEcCtD
Methadone—Phlebitis—Doxorubicin—thyroid cancer	0.000783	0.00409	CcSEcCtD
Methadone—Urticaria—Sorafenib—thyroid cancer	0.00077	0.00402	CcSEcCtD
Methadone—Abdominal pain—Sorafenib—thyroid cancer	0.000766	0.004	CcSEcCtD
Methadone—Body temperature increased—Sorafenib—thyroid cancer	0.000766	0.004	CcSEcCtD
Methadone—Cardiac failure—Epirubicin—thyroid cancer	0.000747	0.0039	CcSEcCtD
Methadone—Hypersensitivity—Sorafenib—thyroid cancer	0.000714	0.00373	CcSEcCtD
Methadone—Asthenia—Sorafenib—thyroid cancer	0.000695	0.00363	CcSEcCtD
Methadone—Cardiac arrest—Epirubicin—thyroid cancer	0.000693	0.00362	CcSEcCtD
Methadone—Cardiac failure—Doxorubicin—thyroid cancer	0.000691	0.00361	CcSEcCtD
Methadone—Pruritus—Sorafenib—thyroid cancer	0.000686	0.00358	CcSEcCtD
Methadone—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000666	0.00348	CcSEcCtD
Methadone—Hypokalaemia—Epirubicin—thyroid cancer	0.000663	0.00346	CcSEcCtD
Methadone—Diarrhoea—Sorafenib—thyroid cancer	0.000663	0.00346	CcSEcCtD
Methadone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000652	0.0034	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000641	0.00335	CcSEcCtD
Methadone—Dizziness—Sorafenib—thyroid cancer	0.000641	0.00335	CcSEcCtD
Methadone—Vomiting—Sorafenib—thyroid cancer	0.000616	0.00322	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000616	0.00322	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000614	0.0032	CcSEcCtD
Methadone—Rash—Sorafenib—thyroid cancer	0.000611	0.00319	CcSEcCtD
Methadone—Dermatitis—Sorafenib—thyroid cancer	0.000611	0.00319	CcSEcCtD
Methadone—Headache—Sorafenib—thyroid cancer	0.000607	0.00317	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000603	0.00315	CcSEcCtD
Methadone—Nausea—Sorafenib—thyroid cancer	0.000576	0.00301	CcSEcCtD
Methadone—Weight increased—Epirubicin—thyroid cancer	0.000573	0.00299	CcSEcCtD
Methadone—Weight decreased—Epirubicin—thyroid cancer	0.00057	0.00298	CcSEcCtD
Methadone—Drowsiness—Epirubicin—thyroid cancer	0.000562	0.00293	CcSEcCtD
Methadone—Sweating—Epirubicin—thyroid cancer	0.000538	0.00281	CcSEcCtD
Methadone—Weight increased—Doxorubicin—thyroid cancer	0.00053	0.00277	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—thyroid cancer	0.000527	0.00275	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—thyroid cancer	0.00052	0.00271	CcSEcCtD
Methadone—Bradycardia—Epirubicin—thyroid cancer	0.000513	0.00268	CcSEcCtD
Methadone—Sweating—Doxorubicin—thyroid cancer	0.000498	0.0026	CcSEcCtD
Methadone—Visual impairment—Epirubicin—thyroid cancer	0.000486	0.00254	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—thyroid cancer	0.000475	0.00248	CcSEcCtD
Methadone—Flushing—Epirubicin—thyroid cancer	0.000468	0.00244	CcSEcCtD
Methadone—Chills—Epirubicin—thyroid cancer	0.000452	0.00236	CcSEcCtD
Methadone—Arrhythmia—Epirubicin—thyroid cancer	0.00045	0.00235	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—thyroid cancer	0.00045	0.00235	CcSEcCtD
Methadone—Erythema—Epirubicin—thyroid cancer	0.000439	0.00229	CcSEcCtD
Methadone—Flushing—Doxorubicin—thyroid cancer	0.000433	0.00226	CcSEcCtD
Methadone—Muscle spasms—Epirubicin—thyroid cancer	0.000422	0.0022	CcSEcCtD
Methadone—Chills—Doxorubicin—thyroid cancer	0.000419	0.00219	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—thyroid cancer	0.000417	0.00218	CcSEcCtD
Methadone—Erythema—Doxorubicin—thyroid cancer	0.000406	0.00212	CcSEcCtD
Methadone—Agitation—Epirubicin—thyroid cancer	0.000403	0.00211	CcSEcCtD
Methadone—Vertigo—Epirubicin—thyroid cancer	0.000394	0.00206	CcSEcCtD
Methadone—Syncope—Epirubicin—thyroid cancer	0.000394	0.00205	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—thyroid cancer	0.00039	0.00204	CcSEcCtD
Methadone—Palpitations—Epirubicin—thyroid cancer	0.000388	0.00202	CcSEcCtD
Methadone—Loss of consciousness—Epirubicin—thyroid cancer	0.000386	0.00201	CcSEcCtD
Methadone—Convulsion—Epirubicin—thyroid cancer	0.00038	0.00199	CcSEcCtD
Methadone—Agitation—Doxorubicin—thyroid cancer	0.000373	0.00195	CcSEcCtD
Methadone—Anxiety—Epirubicin—thyroid cancer	0.000372	0.00194	CcSEcCtD
Methadone—Dry mouth—Epirubicin—thyroid cancer	0.000365	0.00191	CcSEcCtD
Methadone—Vertigo—Doxorubicin—thyroid cancer	0.000365	0.0019	CcSEcCtD
Methadone—Syncope—Doxorubicin—thyroid cancer	0.000364	0.0019	CcSEcCtD
Methadone—Confusional state—Epirubicin—thyroid cancer	0.000361	0.00189	CcSEcCtD
Methadone—Palpitations—Doxorubicin—thyroid cancer	0.000359	0.00187	CcSEcCtD
Methadone—Oedema—Epirubicin—thyroid cancer	0.000358	0.00187	CcSEcCtD
Methadone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000358	0.00187	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000357	0.00186	CcSEcCtD
Methadone—Shock—Epirubicin—thyroid cancer	0.000352	0.00184	CcSEcCtD
Methadone—Convulsion—Doxorubicin—thyroid cancer	0.000352	0.00184	CcSEcCtD
Methadone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000351	0.00183	CcSEcCtD
Methadone—Tachycardia—Epirubicin—thyroid cancer	0.00035	0.00183	CcSEcCtD
Methadone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000346	0.00181	CcSEcCtD
Methadone—Anxiety—Doxorubicin—thyroid cancer	0.000345	0.0018	CcSEcCtD
Methadone—Anorexia—Epirubicin—thyroid cancer	0.000341	0.00178	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—thyroid cancer	0.000338	0.00177	CcSEcCtD
Methadone—Hypotension—Epirubicin—thyroid cancer	0.000335	0.00175	CcSEcCtD
Methadone—Confusional state—Doxorubicin—thyroid cancer	0.000334	0.00174	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000331	0.00173	CcSEcCtD
Methadone—Oedema—Doxorubicin—thyroid cancer	0.000331	0.00173	CcSEcCtD
Methadone—Shock—Doxorubicin—thyroid cancer	0.000326	0.0017	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000325	0.00169	CcSEcCtD
Methadone—Insomnia—Epirubicin—thyroid cancer	0.000324	0.00169	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—thyroid cancer	0.000324	0.00169	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00032	0.00167	CcSEcCtD
Methadone—Somnolence—Epirubicin—thyroid cancer	0.000318	0.00166	CcSEcCtD
Methadone—Anorexia—Doxorubicin—thyroid cancer	0.000316	0.00165	CcSEcCtD
Methadone—Decreased appetite—Epirubicin—thyroid cancer	0.000311	0.00163	CcSEcCtD
Methadone—Hypotension—Doxorubicin—thyroid cancer	0.00031	0.00162	CcSEcCtD
Methadone—Constipation—Epirubicin—thyroid cancer	0.000306	0.0016	CcSEcCtD
Methadone—Pain—Epirubicin—thyroid cancer	0.000306	0.0016	CcSEcCtD
Methadone—Insomnia—Doxorubicin—thyroid cancer	0.0003	0.00157	CcSEcCtD
Methadone—Feeling abnormal—Epirubicin—thyroid cancer	0.000295	0.00154	CcSEcCtD
Methadone—Somnolence—Doxorubicin—thyroid cancer	0.000295	0.00154	CcSEcCtD
Methadone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000293	0.00153	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—thyroid cancer	0.000288	0.0015	CcSEcCtD
Methadone—Urticaria—Epirubicin—thyroid cancer	0.000285	0.00149	CcSEcCtD
Methadone—Constipation—Doxorubicin—thyroid cancer	0.000283	0.00148	CcSEcCtD
Methadone—Pain—Doxorubicin—thyroid cancer	0.000283	0.00148	CcSEcCtD
Methadone—Abdominal pain—Epirubicin—thyroid cancer	0.000283	0.00148	CcSEcCtD
Methadone—Body temperature increased—Epirubicin—thyroid cancer	0.000283	0.00148	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000273	0.00143	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000271	0.00141	CcSEcCtD
Methadone—Hypersensitivity—Epirubicin—thyroid cancer	0.000264	0.00138	CcSEcCtD
Methadone—Urticaria—Doxorubicin—thyroid cancer	0.000263	0.00137	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—thyroid cancer	0.000262	0.00137	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—thyroid cancer	0.000262	0.00137	CcSEcCtD
Methadone—Asthenia—Epirubicin—thyroid cancer	0.000257	0.00134	CcSEcCtD
Methadone—Pruritus—Epirubicin—thyroid cancer	0.000253	0.00132	CcSEcCtD
Methadone—Diarrhoea—Epirubicin—thyroid cancer	0.000245	0.00128	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000244	0.00127	CcSEcCtD
Methadone—Asthenia—Doxorubicin—thyroid cancer	0.000238	0.00124	CcSEcCtD
Methadone—Dizziness—Epirubicin—thyroid cancer	0.000237	0.00124	CcSEcCtD
Methadone—Pruritus—Doxorubicin—thyroid cancer	0.000235	0.00122	CcSEcCtD
Methadone—Vomiting—Epirubicin—thyroid cancer	0.000228	0.00119	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—thyroid cancer	0.000227	0.00118	CcSEcCtD
Methadone—Rash—Epirubicin—thyroid cancer	0.000226	0.00118	CcSEcCtD
Methadone—Dermatitis—Epirubicin—thyroid cancer	0.000226	0.00118	CcSEcCtD
Methadone—Headache—Epirubicin—thyroid cancer	0.000224	0.00117	CcSEcCtD
Methadone—Dizziness—Doxorubicin—thyroid cancer	0.000219	0.00114	CcSEcCtD
Methadone—Nausea—Epirubicin—thyroid cancer	0.000213	0.00111	CcSEcCtD
Methadone—Vomiting—Doxorubicin—thyroid cancer	0.000211	0.0011	CcSEcCtD
Methadone—Rash—Doxorubicin—thyroid cancer	0.000209	0.00109	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—thyroid cancer	0.000209	0.00109	CcSEcCtD
Methadone—Headache—Doxorubicin—thyroid cancer	0.000208	0.00108	CcSEcCtD
Methadone—Nausea—Doxorubicin—thyroid cancer	0.000197	0.00103	CcSEcCtD
Methadone—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	3.83e-05	0.00148	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.78e-05	0.00146	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	3.77e-05	0.00145	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	3.73e-05	0.00144	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—RXRA—thyroid cancer	3.72e-05	0.00144	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CHST14—thyroid cancer	3.72e-05	0.00143	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	3.66e-05	0.00141	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	3.64e-05	0.0014	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CHST14—thyroid cancer	3.63e-05	0.0014	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.56e-05	0.00137	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—SST—thyroid cancer	3.52e-05	0.00136	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.51e-05	0.00136	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CDK1—thyroid cancer	3.5e-05	0.00135	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—TPR—thyroid cancer	3.5e-05	0.00135	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	3.44e-05	0.00133	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MINPP1—thyroid cancer	3.43e-05	0.00132	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	3.39e-05	0.00131	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.35e-05	0.00129	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—SST—thyroid cancer	3.28e-05	0.00127	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	3.25e-05	0.00126	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	3.23e-05	0.00125	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.23e-05	0.00125	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.2e-05	0.00124	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	3.16e-05	0.00122	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CHST14—thyroid cancer	3.15e-05	0.00121	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	3.09e-05	0.00119	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	3.07e-05	0.00119	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TSHR—thyroid cancer	3.05e-05	0.00118	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.02e-05	0.00117	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	3e-05	0.00116	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—HPGD—thyroid cancer	2.99e-05	0.00116	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.99e-05	0.00115	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—SST—thyroid cancer	2.98e-05	0.00115	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—HPGD—thyroid cancer	2.93e-05	0.00113	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.91e-05	0.00113	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.87e-05	0.00111	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MEN1—thyroid cancer	2.87e-05	0.00111	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	2.87e-05	0.00111	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CHST14—thyroid cancer	2.81e-05	0.00108	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.75e-05	0.00106	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CHST14—thyroid cancer	2.74e-05	0.00106	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.74e-05	0.00106	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	2.73e-05	0.00105	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.72e-05	0.00105	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.71e-05	0.00105	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.71e-05	0.00105	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—TPR—thyroid cancer	2.68e-05	0.00103	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TSHR—thyroid cancer	2.68e-05	0.00103	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.66e-05	0.00103	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	2.64e-05	0.00102	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	2.63e-05	0.00102	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—SLC5A5—thyroid cancer	2.62e-05	0.00101	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	2.59e-05	0.001	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	2.59e-05	0.001	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CHST14—thyroid cancer	2.58e-05	0.000997	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CHST14—thyroid cancer	2.56e-05	0.000988	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—HPGD—thyroid cancer	2.54e-05	0.000979	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MEN1—thyroid cancer	2.52e-05	0.000971	CbGpPWpGaD
Methadone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.51e-05	0.000968	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.39e-05	0.000922	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SST—thyroid cancer	2.37e-05	0.000916	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.33e-05	0.000898	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—TPR—thyroid cancer	2.33e-05	0.000898	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.29e-05	0.000884	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CALCA—thyroid cancer	2.28e-05	0.000882	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	2.28e-05	0.000878	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HPGD—thyroid cancer	2.26e-05	0.000874	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TSHR—thyroid cancer	2.26e-05	0.000873	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	2.22e-05	0.000859	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HPGD—thyroid cancer	2.21e-05	0.000853	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—RXRA—thyroid cancer	2.2e-05	0.00085	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CHST14—thyroid cancer	2.19e-05	0.000845	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.13e-05	0.000823	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MEN1—thyroid cancer	2.13e-05	0.000821	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.11e-05	0.000815	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HPGD—thyroid cancer	2.08e-05	0.000804	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SST—thyroid cancer	2.08e-05	0.000803	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDK1—thyroid cancer	2.07e-05	0.000798	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HPGD—thyroid cancer	2.06e-05	0.000797	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.06e-05	0.000794	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.03e-05	0.000783	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—SLC5A5—thyroid cancer	2.01e-05	0.000774	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CALCA—thyroid cancer	2e-05	0.000773	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.93e-05	0.000744	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	1.92e-05	0.000742	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.88e-05	0.000725	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.86e-05	0.000718	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.84e-05	0.000709	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDK1—thyroid cancer	1.81e-05	0.0007	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.8e-05	0.000693	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HPGD—thyroid cancer	1.76e-05	0.000681	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SST—thyroid cancer	1.76e-05	0.000679	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.74e-05	0.000672	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—TPR—thyroid cancer	1.72e-05	0.000664	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.7e-05	0.000658	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CALCA—thyroid cancer	1.69e-05	0.000654	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.69e-05	0.000653	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CHST14—thyroid cancer	1.69e-05	0.000652	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—RXRA—thyroid cancer	1.68e-05	0.00065	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—TPR—thyroid cancer	1.68e-05	0.000649	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.67e-05	0.000646	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRG1—thyroid cancer	1.66e-05	0.000641	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.65e-05	0.000639	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.64e-05	0.000633	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDK1—thyroid cancer	1.53e-05	0.000592	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TERT—thyroid cancer	1.49e-05	0.000575	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000565	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—TPR—thyroid cancer	1.46e-05	0.000562	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRG1—thyroid cancer	1.46e-05	0.000562	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000553	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.43e-05	0.000552	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.43e-05	0.000551	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	1.43e-05	0.00055	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000536	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.36e-05	0.000525	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TERT—thyroid cancer	1.31e-05	0.000505	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TPR—thyroid cancer	1.3e-05	0.000502	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.3e-05	0.000501	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000497	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.28e-05	0.000494	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TPR—thyroid cancer	1.27e-05	0.00049	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.27e-05	0.00049	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.26e-05	0.000486	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	1.26e-05	0.000485	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	1.25e-05	0.000483	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.25e-05	0.000482	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRG1—thyroid cancer	1.23e-05	0.000475	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TPR—thyroid cancer	1.2e-05	0.000462	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TPR—thyroid cancer	1.19e-05	0.000458	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—BRAF—thyroid cancer	1.18e-05	0.000456	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	0.000454	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.17e-05	0.00045	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.16e-05	0.000448	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TERT—thyroid cancer	1.1e-05	0.000426	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	1.1e-05	0.000425	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000422	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000421	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000418	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	1.08e-05	0.000417	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.07e-05	0.000414	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PPARG—thyroid cancer	1.06e-05	0.000411	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—RXRA—thyroid cancer	1.06e-05	0.000408	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.06e-05	0.000408	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	1.06e-05	0.000408	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	0.0004	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.02e-05	0.000394	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TPR—thyroid cancer	1.01e-05	0.000391	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	9.96e-06	0.000385	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	9.73e-06	0.000376	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTEN—thyroid cancer	9.53e-06	0.000368	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SLC5A5—thyroid cancer	9.5e-06	0.000367	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	9.48e-06	0.000366	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	9.3e-06	0.000359	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PPARG—thyroid cancer	9.24e-06	0.000357	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	9.18e-06	0.000355	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—RXRA—thyroid cancer	9.16e-06	0.000354	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.12e-06	0.000352	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.03e-06	0.000349	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.95e-06	0.000346	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	8.93e-06	0.000345	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.91e-06	0.000344	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.87e-06	0.000343	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—BRAF—thyroid cancer	8.75e-06	0.000338	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—thyroid cancer	8.61e-06	0.000333	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—thyroid cancer	8.37e-06	0.000323	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.31e-06	0.000321	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTEN—thyroid cancer	8.31e-06	0.000321	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—RXRA—thyroid cancer	8.18e-06	0.000316	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	8.11e-06	0.000313	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	8.05e-06	0.000311	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	8.01e-06	0.000309	CbGpPWpGaD
Methadone—ABCB1—Metabolism—RXRA—thyroid cancer	7.98e-06	0.000308	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.95e-06	0.000307	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	7.83e-06	0.000302	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TPR—thyroid cancer	7.82e-06	0.000302	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.69e-06	0.000297	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.58e-06	0.000293	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—thyroid cancer	7.55e-06	0.000292	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—RXRA—thyroid cancer	7.52e-06	0.00029	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—RXRA—thyroid cancer	7.45e-06	0.000288	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRAS—thyroid cancer	7.42e-06	0.000286	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—thyroid cancer	7.3e-06	0.000282	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—thyroid cancer	7.29e-06	0.000281	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—thyroid cancer	7.27e-06	0.000281	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.25e-06	0.00028	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	7.11e-06	0.000275	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.1e-06	0.000274	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—thyroid cancer	6.83e-06	0.000264	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	6.81e-06	0.000263	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—thyroid cancer	6.68e-06	0.000258	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	6.62e-06	0.000256	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRAS—thyroid cancer	6.5e-06	0.000251	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—thyroid cancer	6.38e-06	0.000246	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—thyroid cancer	6.38e-06	0.000246	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RXRA—thyroid cancer	6.37e-06	0.000246	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—thyroid cancer	6.34e-06	0.000245	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.2e-06	0.000239	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—thyroid cancer	6.16e-06	0.000238	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	6.01e-06	0.000232	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.85e-06	0.000226	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—thyroid cancer	5.78e-06	0.000223	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—thyroid cancer	5.67e-06	0.000219	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—thyroid cancer	5.6e-06	0.000216	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRAS—thyroid cancer	5.5e-06	0.000212	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—thyroid cancer	5.49e-06	0.000212	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—thyroid cancer	5.43e-06	0.00021	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—thyroid cancer	5.37e-06	0.000207	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—thyroid cancer	5.25e-06	0.000203	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—thyroid cancer	5.16e-06	0.000199	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—thyroid cancer	5.04e-06	0.000195	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—thyroid cancer	4.97e-06	0.000192	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RXRA—thyroid cancer	4.92e-06	0.00019	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—thyroid cancer	4.79e-06	0.000185	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—thyroid cancer	4.76e-06	0.000184	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—thyroid cancer	4.75e-06	0.000183	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—thyroid cancer	4.73e-06	0.000183	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—thyroid cancer	4.71e-06	0.000182	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—thyroid cancer	4.69e-06	0.000181	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—thyroid cancer	4.58e-06	0.000177	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.55e-06	0.000176	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—thyroid cancer	4.21e-06	0.000162	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—thyroid cancer	4.2e-06	0.000162	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—thyroid cancer	4.2e-06	0.000162	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.06e-06	0.000157	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—thyroid cancer	4.02e-06	0.000155	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—thyroid cancer	4.02e-06	0.000155	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—thyroid cancer	3.97e-06	0.000153	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—thyroid cancer	3.96e-06	0.000153	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.73e-06	0.000144	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.7e-06	0.000143	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—thyroid cancer	3.65e-06	0.000141	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—thyroid cancer	3.55e-06	0.000137	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—thyroid cancer	3.54e-06	0.000137	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—thyroid cancer	3.46e-06	0.000133	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—thyroid cancer	3.26e-06	0.000126	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—thyroid cancer	3.23e-06	0.000125	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.16e-06	0.000122	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—thyroid cancer	3.1e-06	0.00012	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—thyroid cancer	2.76e-06	0.000107	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—thyroid cancer	2.7e-06	0.000104	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—thyroid cancer	2.64e-06	0.000102	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.44e-06	9.43e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—thyroid cancer	2.29e-06	8.83e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—thyroid cancer	2.13e-06	8.22e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—thyroid cancer	2.04e-06	7.88e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—thyroid cancer	1.99e-06	7.69e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—thyroid cancer	1.88e-06	7.25e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—thyroid cancer	1.86e-06	7.19e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—thyroid cancer	1.59e-06	6.14e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.23e-06	4.74e-05	CbGpPWpGaD
